Overview

Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety profile and to obtain an indication as to the therapeutic effect of QBECO induction treatment on clinical improvement in moderate to severe Crohn's Disease.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Qu Biologics Inc.